{"database": "lobbying", "table": "lobbying_activities", "rows": [[2525135, "81179b60-d029-4797-b37c-4cb126921c6c", "Q3", "BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC", 292972, "BOEHRINGER INGELHEIM USA CORPORATION", 2020, "third_quarter", "ANI", "Compounding Animal Drugs from Bulk Substances; Draft Guidance for Industry (FDA) - FDA-2018-D-4533\nIssues related to veterinary telehealth \nIssues related to counterfeit products - H.R. 4156\nIssues related to rural broadband \nIssues related to foreign animal disease - H.R. 6921", "Agriculture, Dept of (USDA),Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,SENATE", null, 610000, 0, 0, "2020-10-20T10:25:47.390000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2525135"], "units": {}, "query_ms": 45.53394508548081, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}